Glenmark Pharma Q3 cons net profit up at Rs 109.6 cr

Glenmark Pharma Q3 consolidated net profit was up at Rs 109.6 crore versus Rs 94.1 crore, year-on-year, YoY.

Its consolidated net sales were up at Rs 750.8 crore versus Rs 641.7 crore, YoY.

Source: www.moneycontrol.com

Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd